ALX Oncology
Signal active
Organization
Contact Information
Overview
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company.
The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University. This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.
About
Industries
Biotechnology, Life Science, Health Care, Biopharma, Therapeutics, Oncology
Founded
2015
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ALX Oncology headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Biopharma, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $47.4B in funding across 144 round(s). With a team of 11-50 employees, ALX Oncology is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ALX Oncology, raised $36.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
3
Lead Investors
0
Total Funding Amount
$329.2M
Details
2
ALX Oncology has raised a total of $329.2M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Late Stage Venture | 105.0M | ||
| 2015 | Early Stage Venture | 36.0M |
Investors
ALX Oncology is funded by 28 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ALX Oncology | - | FUNDING ROUND - ALX Oncology | 36.0M |
| venBio Partners | - | FUNDING ROUND - venBio Partners | 36.0M |
| ALX Oncology | - | FUNDING ROUND - ALX Oncology | 36.0M |
| The Longevity Fund | - | FUNDING ROUND - The Longevity Fund | 36.0M |
Recent Activity
There is no recent news or activity for this profile.